Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.

Authors: Jones, Amber B., Tuy, Kaysaw, Hawkins, Cyntanna C., Quinn, Colin H., Saad, Joelle, Gary, Sam E., Beierle, Elizabeth A., Ding, Lei, Rochlin, Kate M., Lamb, Lawrence S., Hjelmeland, Anita B.

Source: Cancers; Aug2024, Vol. 16 Issue 16, p2852, 13p

Subject Terms: COMBINATION drug therapy, GLIOMAS, KILLER cells, T cells, IMMUNOSUPPRESSIVE agents, RESEARCH funding, TEMOZOLOMIDE, ENZYME inhibitors, ANTINEOPLASTIC agents, BLOOD-brain barrier, IMMUNOTHERAPY, IMMUNODIAGNOSIS, CANCER patients, TREATMENT effectiveness, CELLULAR therapy, GENE expression, CELL survival, CELL surface antigens, CELL receptors, IMMUNITY, IMMUNOSUPPRESSION, PHARMACODYNAMICS

MRI-based assessment of function and dysfunction in myelinated axons

Authors: Spees, William M., Lin, Tsen-Hsuan, Sun, Peng, Song, Chunyu, George, Ajit, Gary, Sam E., Yang, Hsin-Chieh, Song, Sheng-Kwei

Source: Proceedings of the National Academy of Sciences of the United States of America, 2018 Oct . 115(43), E10225-E10234.

Access URL: https://www.jstor.org/stable/26532397

Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates.

Authors: Fisher, Jennifer L., Wilk, Elizabeth J., Oza, Vishal H., Gary, Sam E., Howton, Timothy C., Flanary, Victoria L., Clark, Amanda D., Hjelmeland, Anita B., Lasseigne, Brittany N.

Source: FEBS Open Bio; May2024, Vol. 14 Issue 5, p803-830, 28p

Subject Terms: DRUG repositioning, ANTINEOPLASTIC agents, BRAIN tumors, DRUG approval, GENES

The Impact of Peer-Led Learning Groups on First-Year Medical Students.

Authors: Gary, Sam E., Chang, Samuel F., Quinn, Colin H., Baños, James, Hubner, Brook

Source: Medical Science Educator; Oct2024, Vol. 34 Issue 5, p997-999, 3p

Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.

Authors: Estevez-Ordonez, Dagoberto^1,2 (AUTHOR), Gary, Sam E.³ (AUTHOR), Atchley, Travis J.^1,2 (AUTHOR), Maleknia, Pedram D.³ (AUTHOR), George, Jordan A.³ (AUTHOR), Laskay, Nicholas M.B.^1,2 (AUTHOR), Gross, Evan G.³ (AUTHOR), Devulapalli, Rishi K.³ (AUTHOR), Johnston, James M.^1,2 (AUTHOR)

Source: Pediatric Neurosurgery. 2023, Vol. 58 Issue 5, p313-336. 24p.

Subject Terms: *BRAIN tumors, *IMMUNE checkpoint inhibitors, *GERM cell tumors, *THERAPEUTICS, *ONCOLYTIC virotherapy, CENTRAL nervous system tumors

Standard clinical approaches and emerging modalities for glioblastoma imaging.

Authors: Bernstock, Joshua D., Gary, Sam E., Klinger, Neil, Valdes, Pablo A., Essayed, Walid Ibn, Olsen, Hannah E., Chagoya, Gustavo, Elsayed, Galal, Daisuke Yamashita, Schuss, Patrick, Gessler, Florian A., Peruzzi, Pier Paolo, Bag, Asim K., Friedman, Gregory K.

Source: Neuro-Oncology Advances; Jan-Dec2022, Vol. 4 Issue 1, p1-19, 19p

The impact of edema and fiber crossing on diffusion MRI metrics assessed in an ex vivo nerve phantom: Multi‐tensor model vs. diffusion orientation distribution function.

Authors: Ye, Zezhong, Gary, Sam E., Sun, Peng, Mustafi, Sourajit Mitra, Glenn, George Russell, Yeh, Fang‐Cheng, Merisaari, Harri, Song, Chunyu, Yang, Ruimeng, Huang, Guo‐Shu, Kao, Hung‐Wen, Lin, Chien‐Yuan, Wu, Yu‐Chien, Jensen, Jens H., Song, Sheng‐Kwei

Source: NMR in Biomedicine; Jan2021, Vol. 34 Issue 1, p1-16, 16p

Subject Terms: DIFFUSION magnetic resonance imaging, DISTRIBUTION (Probability theory), DIFFUSION tensor imaging, CENTRAL nervous system diseases, EDEMA

Revolutionizing Postoperative Free Flap Monitoring—The Promise of AI to Improve Health Outcomes.

Authors: Ye, Zezhong, Sun, Dan, Gary, Sam E.

Source: JAMA Network Open; 7/26/2024, Vol. 7 Issue 7, pe2424297-e2424297, 1p

Editorial for "Alterations in Resting‐State MR Functional Connectivity of the Central Autonomic Network in Multiple System Atrophy and Relationship With Disease Severity".

Authors: Ye, Zezhong, Gary, Sam E.

Source: Journal of Magnetic Resonance Imaging; Nov2023, Vol. 58 Issue 5, p1488-1489, 2p

Subject Terms: MULTIPLE system atrophy, FUNCTIONAL connectivity, SINGLE-photon emission computed tomography

Mouse macrophage model of Gaucher disease for evaluating non-inhibitory chaperone candidates

Authors: Gary, Sam E., Aflaki, Elma, Berhe, Bahafta, Ory, Daniel, Sidransky, Ellen

Source: In Molecular Genetics and Metabolism February 2018 123(2):S49-S49

Recent advances in the diagnosis and management of Gaucher disease.

Authors: Gary, Sam E., Ryan, Emory, Steward, Alta M., Sidransky, Ellen

Source: Expert Review of Endocrinology & Metabolism; Mar2018, Vol. 13 Issue 2, p107-118, 12p

Subject Terms: GAUCHER'S disease, LYSOSOMAL storage diseases, PHENOTYPES